Clinical trial
Myopia Control Effect of Orthokeratology and 0.01% Atropine Sequential Treatment in Children and Adolescents: A Multicenter Randomized Controlled Trial
NCT06667037 is registered in ClinicalTrials.gov with Zhongshan Ophthalmic Center, Sun Yat-sen University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Myopia Control Effect of Orthokeratology and 0.01% Atropine Sequential Treatment in Children and Adolescents: A Multicenter Randomized Controlled Trial
- Lead sponsor
- Zhongshan Ophthalmic Center, Sun Yat-sen University
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- September 21, 2024
- Completion date
- December 31, 2026
- Enrollment
- 112 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.